Security key
G7487R100
Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC)
CUSIP: G7487R100
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Ordinary Shares, $0.00001 Par Value
- Total 13F shares
- 18,114
- Total 13F value
- $100,442
- Share change
- +17,551
- SEC-reported price per share
- $5.55
- Number of holders
- 2
- Value change
- +$97,348
- Number of buys
- 1
- Number of sells
- 1
- Shares outstanding
- 494,239,409
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
2
Top holders
2
RGC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Regencell Bioscience Holdings Ltd SEC filings
Regencell Bioscience Holdings Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G7487R100
Recent filing periods:
Ownership snapshot
Top reported holders of RGC - Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
UBS Group AG
Disclosed value leader
UBS Group AG
Comparable rows
3/3
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 0%
Quick read
UBS Group AG leads the comparable SEC ownership view at 0%.
3 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens UBS Group AG's linked filing trail.
Comparable ownership
Top 3
UBS Group AG
0%
BlackRock Finance, Inc.
0%
Qube Research & Technologies Ltd
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-3 of 3 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| UBS Group AG |
13F
Company
|
0%
|
$1,048
312 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
0%
|
$800
238 shares
|
— | 30 Jun 2024 |
| Qube Research & Technologies Ltd |
13F
Company
|
0%
|
$44
13 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
18,114
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
3
Q3 2024 holders
2
Holder diff
-1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend